Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-30T02:41:29.084Z Has data issue: false hasContentIssue false
  • English
  • Français

Commentary: Clinical Research on Older Adults in Canada

Published online by Cambridge University Press:  29 November 2010

David B. Hogan  and
Howard Bergman
David B. Hogan
Affiliation:
University of Calgary
Howard Bergman
Affiliation:
McGill University
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentaries/Commentaires
Information
Canadian Journal on Aging / La Revue canadienne du vieillissement , Volume 20 , Issue S1: Northern Lights: Reflections on Canadian Gerontological Research , Summer/Été 2001 , pp. 17 - 20
Copyright
Copyright © Canadian Association on Gerontology 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

(1)DB, Hogan, Bergman, H, PN, McCracken, CJ, Patterson: The history of geriatric medicine in Canada. J Am Geriatr Soc 1997;45:1134–9.CrossRefGoogle Scholar
(2)Poirier, J, Davignon, J, Boutliellier, D, et al: Apolipoprotein E plymorphism and Alzheimer's Disease. Lancet 1993;342(8873):697–9.Google Scholar
(3)PH, St. George-Hyslop: Molecular genetics of Alzheimer's disease. Biological Psychiatry 2000; 47 (3): 183–99.Google Scholar
(4)Janus, C, Pearson, J, McLaurin, J, et al: A-beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 2000; 408: 979–82.CrossRefGoogle Scholar
(5) The Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting enzyme inhibitor on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145–53.Google Scholar
(6)CM, Morin, Colecchi, C, Stone, J, et al: Behavioral and pharmacological therapies for late-life insomnia - a randomized controlled trial. JAMA 1999; 281:991–9.Google Scholar
(7)Podsiadlo, D, Richardson, S: The timed “Up & Go” - a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991; 39: 142–8.Google Scholar
(8)Hebert, R, Carrier, R, Bidoleau, A: The functional autonomy measurement system (SMAF) - description and validation of an instrument for the measurement of handicaps. Age & Ageing 1988; 17: 293–302.Google Scholar
(9)WA, Achenbaum: Crossing Frontiers - Gerontology emerges as a science. Cambridge University Press (Cambridge), 1995.Google Scholar
(10)PA, Rochon, PR, Fortin, KB, Dean, et al: Reporting of age data in clinical trials of arthritis -deficiencies and solutions. Arch Intern Med 1993; 153: 243–48.Google Scholar
(11)RC, Adelman: The Alzheimerization of aging - a brief update. Exp Gerontol 1998; 33 (l-2): 155–7.Google Scholar
(12)Larkin, M: Robert Butler - championing a healthy view of ageing. The Lancet 2001; 357:48.CrossRefGoogle Scholar
(13)JD, Curb: The trials and tribulations of clinical trials in the elderly. J Am Geriatr Soc 1994; 42: 682–3.Google Scholar
(14)AM, Clarfield: Prof. Bernard Isaacs - one of the giants of geriatrics. Geriatrics & Aging 2001; 4 (2): 20-1.Google Scholar